Home
Company
Management
Board of Directors
Governance
Medical and Scientific Advisory Board
Investors
Overview
News / Events
Shareholder Calls / Presentations
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
News & Media
Press Releases
Articles
Reports
Media
Photo Gallery
Contact
Social Media Community Guidelines
Home
Company
– Management
– Board of Directors
– Governance
– Medical and Scientific Advisory Board
– International Diabetes Consortium
Investor Relations
– Overview
– News / Events
– Company Information
– Financial Information
– Stock Data
– SEC Filings
– Corporate Governance
News
– Press Releases
– Articles
– Reports
– Media
– Photo Gallery
Contact
Social Media Community Guidelines
All SEC Filings
Navigation Toggle
Navigation
Overview
News / Events
Shareholder Calls / Presentations
Company Information
Financial Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Quick Links
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Filter Filings:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
05/25/23
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
10
05/19/23
UPLOAD
SEC-generated letter
Related Documents
TEXT-EXTRACT
2
05/19/23
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
05/12/23
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
8
05/11/23
SC TO-I
Issuer tender offer statement
Related Documents
EX-1
EX-1
EX-1
EX-1
EX-1
EX-1
EX-5
EX-FILING FEES
56
05/11/23
8-K
Current report filing
Related Documents
EX-3.1
EX-4.1
EX-10.1
EX-10.2
EX-10.3
EX-99.1
87
03/16/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Related Documents
EX-3.2
EX-31.1
EX-31.2
EX-32.1
EX-32.2
32
02/14/23
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
02/08/23
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/02/23
8-K
Current report filing
Related Documents
EX-99.1
3
<< Previous
1
2
3
4
5
6
7
8
9
10
...42
Next >>